Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
about
Human immunodeficiency virus-associated pulmonary arterial hypertensionPharmacokinetic drug-drug interaction and their implication in clinical managementIdentification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafilDrug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir.Pharmacotherapy of sexual dysfunctions : current status.Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males.Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomicsHardness, function, emotional well-being, satisfaction and the overall sexual experience in men using 100-mg fixed-dose or flexible-dose sildenafil citratePathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesSildenafil and bosentan plasma concentrations in a human immunodeficiency virus- infected patient with pulmonary arterial hypertension treated with ritonavir-boosted protease inhibitorPulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the LiteratureSexual Dysfunctions of HIV-Positive Men: Associated Factors, Pathophysiology Issues, and Clinical Management.Emerging oral drugs for erectile dysfunction.Quality of drug information on the World Wide Web and strategies to improve pages with poor information quality. An intervention study on pages about sildenafil.The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction.The role of cytochrome P450 in antiretroviral drug interactions.Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension.Pulmonary arterial hypertension in human immunodeficiency virus infection.Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review.Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.Sexual evaluation and treatment of ageing males with haemophilia.HIV infection and pulmonary arterial hypertension.Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment.Urological aspects of HIV and AIDS.HIV-associated pulmonary arterial hypertension: from bedside to the future.Pharmacological treatment of HIV-associated pulmonary hypertension.CYP3A activity: towards dose adaptation to the individual.Non-infectious pulmonary disorders in HIV.A Phase I study to assess the safety, tolerability and pharmacokinetic profile of boceprevir and sildenafil when dosed separately and together, in healthy male volunteers.Substantially increased sildenafil bioavailability after sublingual administration in children with congenital heart disease: two case reports.Re: 'Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir'The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.Clinical update on sildenafil citrate.The effects of cimetidine and antacid on the pharmacokinetic profile of sildenafil citrate in healthy male volunteers.Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase.Effect of hepatic CYP inhibitors on the metabolism of sildenafil and formation of its metabolite, N-desmethylsildenafil, in rats in vitro and in vivo.Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients.
P2860
Q26824782-DBAD5F3E-069A-4A6A-8A23-DF048C6BC350Q27021051-DA32792C-60CF-447F-A4E4-B7C38A0CEF9CQ28362294-1B5033F4-730E-407B-8D7B-ED0A5CE27C88Q30249162-924D02C3-FBED-48C5-A054-ACDC2CE84829Q33186873-030BBF2F-2F72-4E4F-9FC9-E0DE8D5AB89AQ34183723-3C6569D4-A7AD-4CD6-9648-F75D377F0076Q34317045-995DD08E-E720-43B6-A451-905DD79C9144Q34344390-28BD4E4E-6514-43B1-84CF-299272E5B367Q34666969-D551412D-DAF3-4A46-88A8-1FDB63D479E3Q35095050-0395256B-CB49-4E15-B424-BCB94E20C528Q35156618-52E61CAC-6A72-4964-9675-50C19CD1A233Q35290066-67637A2E-D31B-4215-9E0E-CCEE2EE3A5CDQ35296597-FE0904BB-783A-4398-9379-4807F99A8501Q35419887-CAA4F42D-80A5-4F4E-95AA-378350845B47Q35779307-897635A9-39B4-46E4-90C8-5752A64BE815Q35825904-C7D93843-835F-4475-9AFD-9CC2B8D839FCQ36229351-F2C3BA1F-16FB-4859-8F24-DE4028A100C6Q36572591-784D0F84-D296-4EDA-B94C-DECD44F6492BQ36909336-4E634061-779E-4CE3-8E9A-4A67C9E4482AQ37481861-D12B6B2D-D16C-4BD7-BABD-2A76AD401592Q37612691-91911D2E-BD3D-4150-8165-713354A8FEA8Q37824590-692DADC5-8684-4C6B-B779-E34B8726C87BQ37845854-FD75B11C-253D-4BB4-81AC-6209E37A3539Q37849338-BFBC197A-6B9D-4B51-A582-F84BCFC25E3FQ37867676-2030309E-FF70-4A7E-9F0C-BE9D55CB1A62Q38128886-5AFDE06D-28B9-429B-AB94-9BC5D73EDDB1Q38156073-AD23F76F-CF1A-4C81-9986-4DB5F44179CFQ38365222-EF74E6F3-BC1F-491B-9878-997F26C690F8Q38728500-2F678E20-572A-4B79-AA74-9F582138714EQ38763583-67A4CECE-E929-4747-AB46-63123794CF2EQ39106214-D2971B60-2677-40E5-A47C-0C0E62C53FA2Q41476481-506C4A48-1C3F-4F8C-96E4-76F589F42ADEQ41580751-CBCB4168-0121-404A-B874-0563B3580E6FQ41597154-FF8E6E53-2C9D-42B3-9DD6-6AA3392CF780Q42284377-024FAD41-208B-430B-BB0E-9746FFAF1F21Q42780422-DEEF0162-68B6-4F9A-B438-612815A4850AQ42780497-6C9AC023-ADD4-487A-8E2D-C3310970C12CQ42931493-5012A5DB-FD7A-457B-A6C9-F115B7897532Q43230729-B66FB430-A293-4121-B146-B048F4870C8CQ43254867-E83278BE-D15A-4F7D-8AF0-A4737FE7372E
P2860
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@ast
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@en
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@nl
type
label
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@ast
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@en
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@nl
prefLabel
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@ast
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@en
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@nl
P2093
P2860
P1476
Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
@en
P2093
A Fielding
D Kleinermans
G J Muirhead
P2860
P304
P356
10.1046/J.1365-2125.2000.00245.X
P407
P577
2000-08-01T00:00:00Z